Avantor, Inc. Share Price

Equities

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 26/04/2024 BST 5-day change 1st Jan Change
23.94 USD -4.81% Intraday chart for Avantor, Inc. -0.66% +4.86%
Sales 2024 * 6.95B 557B Sales 2025 * 7.33B 587B Capitalization 16.26B 1,302B
Net income 2024 * 450M 36.03B Net income 2025 * 624M 49.96B EV / Sales 2024 * 3.01 x
Net Debt 2024 * 4.66B 373B Net Debt 2025 * 3.9B 312B EV / Sales 2025 * 2.75 x
P/E ratio 2024 *
33.6 x
P/E ratio 2025 *
25.1 x
Employees 14,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.69%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 30/04/14
Director of Finance/CFO 54 06/08/23
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 54 31/10/21
Director/Board Member 68 06/05/20
Chairman 66 31/03/17
More insiders
Date Price Change Volume
26/04/24 23.94 -4.81% 14,185,165
25/04/24 25.15 -1.22% 6,252,933
24/04/24 25.46 -0.74% 6,282,431
23/04/24 25.65 +5.08% 5,609,607
22/04/24 24.41 +1.29% 5,532,766

Delayed Quote Nyse, April 26, 2024 at 09:00 pm

More quotes
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
23.94 USD
Average target price
27.69 USD
Spread / Average Target
+15.68%
Consensus